Physician Financial Incentives for Use of Outpatient Intravenous Antimicrobial Therapy: An Interrupted Time Series Analysis
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciad082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von John A Staples und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Outpatients, Anti-Infective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: an unrestricted, Vancouver Coastal Health Research Institute.
Abstract (Originalsprache)
Background
In 2011, policymakers in British Columbia introduced a fee-for-service payment to incentivize infectious diseases physicians to supervise outpatient parenteral antimicrobial therapy (OPAT). Whether this policy increased use of OPAT remains uncertain.
Methods
We conducted a retrospective cohort study using population-based administrative data over a 14-year period (2004–2018). We focused on infections that required intravenous antimicrobials for ≥10 days (eg, osteomyelitis, joint infection, endocarditis) and used the monthly proportion of index hospitalizations with a length of stay shorter than the guideline-recommended “usual duration of intravenous antimicrobials” (LOS < UDIVA) as a surrogate for population-level OPAT use. We used interrupted time series analysis to determine whether policy introduction increased the proportion of hospitalizations with LOS < UDIVA.
Results
We identified 18 513 eligible hospitalizations. In the pre-policy period, 82.3% of hospitalizations exhibited LOS < UDIVA. Introduction of the incentive was not associated with a change in the proportion of hospitalizations with LOS < UDIVA, suggesting that the policy intervention did not increase OPAT use (step change, −0.06%; 95% confidence interval [CI], −2.69% to 2.58%; P = .97 and slope change, −0.001% per month; 95% CI, −.056% to .055%; P = .98).
Conclusions
The introduction of a financial incentive for physicians did not appear to increase OPAT use. Policymakers should consider modifying the incentive design or addressing organizational barriers to expanded OPAT use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of British Columbia, Vancouver, Canada.
- Centre for Clinical Epidemiology & Evaluation, Vancouver, Canada.
- Center for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, Canada.
- Department of Emergency Medicine, University of British Columbia, Vancouver, Canada.
- Department of Statistics, University of British Columbia, Vancouver, Canada.
- Centre for Health Evaluation & Outcome Sciences, Vancouver, Canada.
Förderung
- an unrestricted
- Vancouver Coastal Health Research Institute
Zitieren
APA
Staples, J. A., Ho, M., Ferris, D., Liu, G., Brubacher, J. R., Khan, M., Daly-Grafstein, D., Tran, K. C., & Sutherland, J. M. (2023). Physician Financial Incentives for Use of Outpatient Intravenous Antimicrobial Therapy: An Interrupted Time Series Analysis. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad082
Vancouver
Staples JA, Ho M, Ferris D, Liu G, Brubacher JR, Khan M, et al. Physician Financial Incentives for Use of Outpatient Intravenous Antimicrobial Therapy: An Interrupted Time Series Analysis. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad082
BibTeX
@article{Staples2023,
author = {Staples, John A and Ho, Meghan and Ferris, Dwight and Liu, Guiping and Brubacher, Jeffrey R and Khan, Mayesha and Daly-Grafstein, Daniel and Tran, Karen C and Sutherland, Jason M},
title = {Physician Financial Incentives for Use of Outpatient Intravenous Antimicrobial Therapy: An Interrupted Time Series Analysis},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciad082}
}
EUVIMED